| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233583 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 8 Pages |
Abstract
Even minor differences in radiation dose in neoadjuvant regimens for locally advanced cervical cancer are crucial for determining the balance between a tolerogenic and an efficacious antitumor immune response in TDLN. Because most of the anticancer immune response takes place in TDLN, the present findings also emphasize the importance of chemoradiation protocols in the context of immunotherapeutic trials.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Alessandra M.Sc., Alexia B.Sc., Enrica M.Sc., Mara B.Sc., Marco M.D., Gabriella M.D., Giovanni M.D., Andrea M.D.,